MedPath

Evaluation of the effect of extract of nettle (Urtica Dioica) on blood glucose in adolescent patients with type 1 diabetes , A Randomized Double Blinded Controlled Trial

Phase 2
Conditions
Type 1 diabetes - insulin - children.
Insulin-dependent diabetes mellitus
Registration Number
IRCT20220516054879N2
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

12-18 years old Patients with type 1 diabetes treated with insulin
and with improper blood sugar control (A1C greater than 6.5 mg / dl)
provided that their BUN and serum creatinine are satisfactory and the patient does not classified as a patient with renal impairment.(BUN 8-20 mg / dL and creatinine less than 1.5 mg / dL.)

Exclusion Criteria

Patient reluctance
Patient taking lithium, warfarin and antihypertensive drugs Due to the existence of drug interactions according to the WHO source
History of previous allergies to nettle edible products
Change of more than 0.3 units in the parameters of patient's renal function

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting blood glucose sugar reduction. Timepoint: The variable will be measured at the beginning of the study, 4, 8 and 12 weeks after the start of the study. Method of measurement: Home glucose testing devices or blood tests.
Secondary Outcome Measures
NameTimeMethod
A1C reduction. Timepoint: This variable will be measured at the beginning of the study and 12 weeks after the start of the study. Method of measurement: blood test.;Insulin dose reduction. Timepoint: This variable will be measured at the beginning of the study and 12 weeks after the start of the study. Method of measurement: blood test.
© Copyright 2025. All Rights Reserved by MedPath